UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO/A
(Amendment No. 4)
Tender
Offer Statement under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
LIFECELL CORPORATION
(Name of Subject Company (Issuer))
Leopard Acquisition Sub, Inc.
and
Kinetic Concepts, Inc.
(Names of Filing Persons (Offerors))
Common Stock, par value
$0.001 per share
(Title of Class of Securities)
531927101
(CUSIP Number of Class of Securities)
Stephen D. Seidel, Esq.
Sr. Vice
President, General Counsel and Secretary
Kinetic Concepts, Inc.
8023 Vantage Drive
San Antonio, TX 78230
(210) 524-9000
(Name,
Address and Telephone Numbers of Person Authorized
to Receive Notices and Communications on Behalf of Filing
Persons)
Copy to:
Charles W.
Mulaney, Jr., Esq.
Shilpi Gupta, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
333 West Wacker Drive, Suite 2300
Chicago, IL 60606
(312) 407-0700
CALCULATION OF FILING FEE
|
|
|
Transaction Valuation*
|
|
Amount of Filing Fee**
|
$1,868,966,910
|
|
$73,450.40
|
*
|
Estimated for purposes of calculating the amount of the filing fee in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended (the Exchange Act).
The transaction value was calculated by multiplying the tender offer price of $51.00 per share by the number of shares of common stock, par value $0.001 per share, of LifeCell Corporation (Shares) outstanding on a fully diluted basis to
be acquired in the tender offer as of April 7, 2008, based upon representations by LifeCell Corporation in the Agreement and Plan of Merger dated as of April 7, 2008 (the Merger Agreement), among LifeCell Corporation, Kinetic
Concepts, Inc. and Leopard Acquisition Sub, Inc., consisting of (a) 34,203,446 Shares issued and outstanding, (b) 2,101,510 Shares subject to outstanding LifeCell stock options and (c) 341,454 Shares subject to outstanding LifeCell
restricted stock unit awards.
|
**
|
The filing fee, calculated in accordance with Rule 0-11 of the Securities Exchange Act of 1934, is calculated by multiplying the Transaction Valuation by .00003930.
|
þ
|
Check the box if any part of the fee is offset as provided by Rule 0-11 (a) (2) and identify the filing with which the offsetting fee was previously paid. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
Amount Previously Paid: $73,450.40
|
|
Filing Party: Kinetic Concepts, Inc
and Leopard
Acquisition Sub, Inc.
|
|
|
Form or Registration No.: Schedule TO
|
|
Date Filed: April 21, 2008
|
¨
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
Check the appropriate boxes below to designate any transactions to which the statement relates:
þ
|
third-party tender offer subject to Rule 14d-1.
|
¨
|
issuer tender offer subject to Rule 13e-4.
|
¨
|
going-private transaction subject to Rule 13e-3.
|
¨
|
amendment to Schedule 13D under Rule 13d-2.
|
Check the
following box if the filing is a final amendment reporting the results of the tender offer:
¨
This Amendment No. 4 amends and supplements the Tender Offer Statement on Schedule TO (the
Schedule TO) originally filed with the Securities and Exchange Commission on April 21, 2008 and as amended and supplemented on April 21, 2008, April 30, 2008 and May 12, 2008 by Kinetic Concepts, Inc., a Texas
corporation (KCI), and Leopard Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of KCI (Purchaser). The Schedule TO relates to the Purchasers tender offer for all of the outstanding shares of
common stock, par value $0.001 per share (the Shares), of LifeCell Corporation, a Delaware corporation (LifeCell), for $51.00 per Share, net to the seller in cash (subject to applicable withholding taxes), without interest,
upon the terms and subject to the conditions set forth in the Offer to Purchase, dated April 21, 2008, as amended (the Offer to Purchase) and the related Letter of Transmittal (which, together with the Offer to Purchase, as each may
be amended or supplemented from time to time, collectively constitute the Offer), which were filed as exhibits (a)(1)(A) and (a)(1)(B) to the Schedule TO.
Unless otherwise defined herein, all capitalized terms used herein shall have the respective meanings given such terms in the Schedule TO. The item numbers and responses thereto below are in accordance with the
requirements of Schedule TO.
The items of the Schedule TO (as previously amended) set forth below are hereby amended and supplemented as
follows:
Item 11.
Additional Information.
Item 11 of the Schedule TO (as previously amended) is hereby amended and supplemented by adding the following text hereto:
The initial period of the Offer expired at 12:00 midnight, New York City time, on Friday, May 16, 2008. All of the conditions to the Offer have
been satisfied. Accordingly, on May 19, 2008, Purchaser accepted for payment in accordance with the terms of the Offer all Shares that were validly tendered and not withdrawn prior to the expiration of the Offer (including all Shares properly
delivered through notices of guaranteed delivery), and payment for such Shares will be made promptly, in accordance with the terms of the Offer. The Depositary for the Offer has advised KCI and Purchaser that, as of the expiration of the Offer, a
total of approximately 31.25 million Shares were validly tendered to Purchaser and not withdrawn (including approximately 6.2 million Shares delivered through notices of guaranteed delivery), representing approximately 91.3% of the Shares
outstanding. Shares tendered through notices of guaranteed delivery are required to be delivered to Purchaser by Wednesday, May 21, 2008.
On May 19, 2008, KCI announced in a press release that Purchaser has commenced a subsequent offering period to acquire all remaining untendered Shares. The subsequent offering period is scheduled to expire at 6:00 p.m., New York City
time, on Friday, May 23, 2008, unless further extended. During the subsequent offering period, holders of Shares who did not previously tender their Shares into the Offer may do so and will promptly receive the same $51.00 per Share cash
consideration, without interest, paid during the initial offering period of the Offer. Purchaser will immediately accept all Shares properly tendered during the subsequent offering period and will pay the tendering stockholders promptly after
acceptance. Shares tendered during the subsequent offering period may not be withdrawn. KCI and Purchaser reserve the right to extend the subsequent offering period in accordance with applicable law. The full text of the press release issued by KCI
is attached hereto as Exhibit (a)(1)(M) and is incorporated herein by reference.
Item 12.
Exhibits.
Item 12 of the Schedule TO is hereby amended and supplemented to add the following exhibit:
(a)(1)(M) Press release issued by KCI, dated May 19, 2008
2
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
KINETIC CONCEPTS, INC.
|
|
|
By:
|
|
/s/ Stephen D. Seidel
|
Name:
|
|
Stephen D. Seidel
|
Title:
|
|
Sr. Vice President, General Counsel
and Secretary
|
|
|
|
LEOPARD ACQUISITION SUB, INC.
|
|
|
By:
|
|
/s/ Stephen D. Seidel
|
Name:
|
|
Stephen D. Seidel
|
Title:
|
|
Vice President, Secretary
|
Dated: May 19, 2008
3
EXHIBIT INDEX
|
|
|
(a)(1)(A)
|
|
Offer to Purchase, dated April 21, 2008
|
|
|
(a)(1)(B)
|
|
Form of Letter of Transmittal
|
|
|
(a)(1)(C)
|
|
Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9
|
|
|
(a)(1)(D)
|
|
Form of Notice of Guaranteed Delivery
|
|
|
(a)(1)(E)
|
|
Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
|
|
|
(a)(1)(F)
|
|
Form of Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
|
|
|
(a)(1)(G)
|
|
Letter from KCI to participants in The LifeCell Corporation Employee Stock Purchase Plan
|
|
|
(a)(1)(H)
|
|
Text of joint press release issued by KCI and LifeCell, dated April 7, 2008 (incorporated by reference to Exhibit 99.1 of the Current Report on Form 8-K filed by KCI with the Securities and
Exchange Commission on April 7, 2008)
|
|
|
(a)(1)(I)
|
|
KCI Investor Presentation dated April 7, 2008 (incorporated by reference to Exhibit 99.1 of the Schedule TO-C filed by KCI and Purchaser with the Securities and Exchange Commission on April 7,
2008)
|
|
|
(a)(1)(J)
|
|
KCI Investor Call Transcript dated April 7, 2008 (incorporated by reference to Exhibit 99.1 of the Schedule TO-C filed by KCI and Purchaser with the Securities and Exchange Commission on April
8, 2008)
|
|
|
(a)(1)(K)
|
|
Form of summary advertisement, published April 21, 2008
|
|
|
(a)(1)(L)
|
|
Press Release issued by KCI, dated April 21, 2008
|
|
|
(a)(1)(M)
|
|
Press Release issued by KCI, dated May 19, 2008
|
|
|
(b)(1)
|
|
Debt Commitment Letter dated April 7, 2008, by and among KCI, Bank of America, N.A., Banc of America Securities LLC, JPMorgan Chase Bank, N.A. and J.P. Morgan Securities Inc. incorporated by
reference to Exhibit 10.1 of the Current Report on Form 8-K filed by KCI with the Securities and Exchange Commission on April 7, 2008
|
|
|
(d)(1)
|
|
Agreement and Plan of Merger dated as of April 7, 2008, by and among KCI, Purchaser and LifeCell (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by KCI with the
Securities and Exchange Commission on April 7, 2008)
|
|
|
(d)(2)
|
|
Confidentiality Letter Agreement dated February 4, 2008, between LifeCell and KCI
|
|
|
(g)
|
|
Not applicable
|
|
|
(h)
|
|
Not applicable
|
4
Lifecell Corp (MM) (NASDAQ:LIFC)
Historical Stock Chart
From Apr 2024 to May 2024
Lifecell Corp (MM) (NASDAQ:LIFC)
Historical Stock Chart
From May 2023 to May 2024